Breast implant seroma: A SARS-CoV-2 mRNA vaccine side effect.

Kayser, Françoise;Fourneau, Hadrien;Mazy, Olivier;Mazy, Stéphane
(2021) Journal of Clinical Ultrasound — Vol. 49, n° 9, p. 984-986 (2021)

Files

KayserFJClinUltrasound2021.pdf
  • Open Access
  • Adobe PDF
  • 528.58 KB

Details

Authors
  • Author
  • Fourneau, Hadrienorcid-logoUCLouvain
    Author
  • Mazy, Olivierorcid-logoUCLouvain
    Author
  • Mazy, Stéphaneorcid-logoUCLouvain
    Author
Abstract
Fluid collection surrounding breast implants, called seroma, is a frequent issue that has diverse etiologies. We describe a 48-year-old woman with an acute onset of bilateral breast swelling occurring 5 years after aesthetic surgery and 10 days after a second SARS-CoV-2 mRNA vaccine dose. At breast ultrasound, we found an abundant bilateral peri-implant seroma. Our patient noticed symptom improvement 48 h after nonsteroidal anti-inflammatory drug treatment, complete disappearance of symptoms after 10 days with seroma disappearance documented by ultrasound. We hypothesized a breast implant seroma as post-SARS-CoV-2 mRNA vaccine side effect, as different other diagnosis had been excluded.
Affiliations

Citations

Kayser, F., Fourneau, H., Mazy, O., & Mazy, S. (2021). Breast implant seroma: A SARS-CoV-2 mRNA vaccine side effect. Journal of Clinical Ultrasound, 49(9), 984-986. https://doi.org/10.1002/jcu.23056 (Original work published 2021)